image
VIRUS OUTBREAK EUROPE VACCINES
FILE - In this Jan. 2, 2021 file photo a vial of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca is checked as they arrive at the Princess Royal Hospital in Haywards Heath, England. The European Medicines Agency is expected on Friday Jan. 29, 2021 to authorize use of the vaccine AstraZeneca developed with Oxford University. It would be the third cleared for use in the EU, after the BioNTech-Pfizer and Moderna vaccines. (Gareth Fuller/Pool via AP, File)
Instructions
POOL - Jan. 2, 2021 file photo
License
Rights Managed
Date created
20210102
Place
HAYWARDS HEATH GROSSBRITANNIEN
Credit
KEYSTONE
Source
AP Pool
Byline
GARETH FULLER
Size
3500 x 2310 px
File type
JPEG